SCHEMBL2500590

SCHEMBL2500590

C1=C[N]C2=CCC=NC2=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3338127 0.69 — —
SCHEMBL17069792 0.59 NOTUM (0.39) —
SCHEMBL9465196 0.59 MAPT (0.46) —
SCHEMBL2502136 0.58 — —
SCHEMBL1827788 0.57 — —
SCHEMBL5602945 0.57 TDP1 (0.33) —
SCHEMBL3601974 0.56 ALDH1A1 (0.38) —
SCHEMBL9465439 0.55 — —
SCHEMBL9466069 0.55 PTK2 (0.41) —
SCHEMBL9465420 0.55 KDM4A (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110245156-A1 NOVEL ANTIVIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE CYTOKINE PHARMASCIENCES, INC. (US) 2011-10-06 — — US claimed
US-20110245156-A1 NOVEL ANTIVIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE CYTOKINE PHARMASCIENCES, INC. (US) 2011-10-06 — — US disclosed
Send feedback